Table 1.
Median (range) |
||||
---|---|---|---|---|
Inflammation | Hyperplasia | GIN | Gross tumors | |
1 week | ||||
Sham (n=6) | 0 (0–0) | 1 (0–1) | 0 (0–0) | NA |
NTBF (n=4) | 0 (0–0) | 0 (0–0) | 0 (0–0) | NA |
ETBF (n=16) | 2 (0–3)a | 3 (2–4)b | 1.5 (0–4)c | NA |
4–6 weeks | ||||
Sham (n=9) | 0 (0–1) | 0 (0–1) | 0 (0–0) | 2 (0–8) |
NTBF (n=5) | 0 (0–0) | 0 (0–1) | 0 (0–0) | 3 (2–4) |
ETBF (n=59) | 1 (0–3)d | 2 (1–4)e | 1 (0–16)f | 9 (2–49)g |
NA, not applicable.
P < 0.015 versus 1 week sham and NTBF; independent comparisons.
P < 0.0004 versus 1 week sham and NTBF; independent comparisons.
P < 0.042 versus 1 week sham and NTBF; independent comparisons.
P < 0.0006 versus 4–6 week sham and NTBF; independent comparisons.
P < 0.0004 versus 4–6 week sham and NTBF; independent comparisons.
P < 0.018 versus 4–6 week sham and P =0.10 versus NTBF; independent comparisons.
P < 0.0005 versus 4–6 week sham and NTBF; independent comparisons.